AUTUMN ELLIS: Open Payments
NPI 1194301242 · HALLS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 79 payments from 12 companies in 2025. Trend: 2023 $798 · 2024 $853 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $344 |
| Novo Nordisk Inc | 22 | $324 |
| AstraZeneca Pharmaceuticals LP | 10 | $297 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $201 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| PFIZER INC. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: Ozempic, CAPLYTA, QULIPTA, VRAYLAR, BREZTRI, AIRSUPRA, FARXIGA, UBRELVY.
Industry payments across TN — which companies pay providers there.
